News

Le Lézard10h
Extendicare Announces Agreement to Acquire Closing the Gap Healthcare Group
Extendicare Inc. ("Extendicare" or the "Company") announced today that its wholly owned home health care subsidiary, ParaMed Inc. ("ParaMed" or the "Purchaser"), has entered into an agreement to ...
MedPage Today on MSN8h
FDA Approves Sapien 3 TAVR for Asymptomatic Aortic Stenosis
FDA approved the Sapien 3 transcatheter aortic valve replacement (TAVR) platform for treatment of severe aortic stenosis ...
Healio7h
FDA approves first TAVR platform to treat severe asymptomatic aortic stenosis
Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...
TCTMD9h
FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis
The agency’s decision for the balloon-expandable Sapien 3 platform is based on groundbreaking results from EARLY TAVR.
MassDevice9h
Edwards wins FDA nod for TAVR in aortic stenosis without symptoms
Edwards Lifesciences (NYSE: EW) received FDA approval for its Sapien 3 TAVR for severe aortic stenosis (AS) without symptoms.